# Random-start Ovarian Stimulation in Egg-donors (ROSE)

> **NCT02821819** · PHASE4 · TERMINATED · sponsor: **Instituto Bernabeu** · enrollment: 15 (actual)

## Conditions studied

- Infertility

## Interventions

- **OTHER:** Random start ovarian stimulation
- **DRUG:** Gonadotrophins
- **DRUG:** GnRH antagonist
- **DRUG:** GnRH agonist

## Key facts

- **NCT ID:** NCT02821819
- **Lead sponsor:** Instituto Bernabeu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-10
- **Primary completion:** 2018-01-12
- **Final completion:** 2018-01-12
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Difficult recruitment
- **Last updated:** 2019-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02821819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02821819, "Random-start Ovarian Stimulation in Egg-donors (ROSE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02821819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*